247
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Development of Emu oil-loaded PCL/collagen bioactive nanofibers for proliferation and stemness preservation of human adipose-derived stem cells: possible application in regenerative medicine

, , , , &
Pages 1978-1988 | Received 04 May 2017, Accepted 16 Jul 2017, Published online: 10 Aug 2017

References

  • Nejati-Koshki K, Mortazavi Y, Pilehvar-Soltanahmadi Y, et al. An update on application of nanotechnology and stem cells in spinal cord injury regeneration. Biomed Pharmacother. 2017;90:85–92.
  • Alizadeh E, Akbarzadeh A, Eslaminejad MB, et al. Up regulation of liver‐enriched transcription factors HNF4a and HNF6 and liver‐specific microRNA (miR‐122) by inhibition of let‐7b in mesenchymal stem cells. Chem Biol Drug Des. 2015;85:268–279.
  • Mobarak H, Fathi E, Farahzadi R, et al. L-carnitine significantly decreased aging of rat adipose tissue-derived mesenchymal stem cells. Vet Res Commun. 2017;41:41–47.
  • Oh S, Brammer KS, Li YJ, et al. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci USA. 2009;106:2130–2135.
  • Ravichandran R, Ng CC, Liao S, et al. Biomimetic surface modification of titanium surfaces for early cell capture by advanced electrospinning. Biomed Mater. 2011;7:015001.
  • Pilehvar-Soltanahmadi Y, Akbarzadeh A, Moazzez-Lalaklo N, et al. An update on clinical applications of electrospun nanofibers for skin bioengineering. Artif Cells Nanomed Biotechnol. 2016;44:1350–1364.
  • Deldar Y, Pilehvar-Soltanahmadi Y, Dadashpour M, et al. An in vitro examination of the antioxidant, cytoprotective and anti-inflammatory properties of chrysin-loaded nanofibrous mats for potential wound healing applications. Artif Cells Nanomed Biotechnol. Forthcoming. [11 p.]. http://dx.doi.org/10.1080/21691401.2017.1337022.
  • Dadashpour M, Pilehvar-Soltanahmadi Y, Mohammadi SA, et al. Watercress-based electrospun nanofibrous scaffolds enhance proliferation and stemness preservation of human adipose-derived stem cells. Artif Cells Nanomed Biotechnol. Forthcoming. [12 p.]. doi:10.1080/21691401.2017.1345925.
  • Tan AW, Pingguan-Murphy B, Ahmad R, et al. Advances in fabrication of TiO2 nanofiber/nanowire arrays toward the cellular response in biomedical implantations: a review. J Mater Sci. 2013;48:8337–8353.
  • Ghoraishizadeh S, Ghorishizadeh A, Ghoraishizadeh P, et al. Application of nanoscaffolds in mesenchymal stem cell-based therapy. Adv Regenerative Med. 2014;2014:1–14.
  • Gauthaman K, Venugopal JR, Yee FC, et al. Nanofibrous substrates support colony formation and maintain stemness of human embryonic stem cells. J Cell Mol Med. 2009;13:3475–3484.
  • Jung YH, Lee S-J, Oh SY, et al. Oleic acid enhances the motility of umbilical cord blood derived mesenchymal stem cells through EphB2-dependent F-actin formation. Biochim Biophys Acta – Mol Cell Res. 2015;1853:1905–1917.
  • Kamath MS, Ahmed SS, Dhanasekaran M, et al. Polycaprolactone scaffold engineered for sustained release of resveratrol: therapeutic enhancement in bone tissue engineering. Int J Nanomed. 2013;9:183–195.
  • Sung H-J, Meredith C, Johnson C, et al. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials. 2004;25:5735–5742.
  • Sisson AL, Ekinci D, Lendlein A. The contemporary role of ε-caprolactone chemistry to create advanced polymer architectures. Polymer. 2013;54:4333–4350.
  • Shuai Y, Liao L, Su X, et al. Melatonin treatment improves mesenchymal stem cells therapy by preserving stemness during long-term in vitro expansion. Theranostics. 2016;6:1899.
  • Zarghami N, Sheervalilou R, Fattahi A, et al. An overview on application of natural substances incorporated with electrospun nanofibrous scaffolds to development of innovative wound dressings. Mini Rev Med Chem. 2017;17.
  • Pourhassan-Moghaddam M, Zarghami N, Mohsenifar A, et al. Watercress-based gold nanoparticles: biosynthesis, mechanism of formation and study of their biocompatibility in vitro. Micro Nano Lett. 2014;9:345–350.
  • Nejati-Koshki K, Mesgari M, Ebrahimi E, et al. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA–PEG6000 copolymers in treatment of lung cancer. J Microencapsul. 2014;31:815–823.
  • Montazeri M, Sadeghizadeh M, Pilehvar-Soltanahmadi Y, et al. Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines. Int J Pharm. 2016;509:244–254.
  • Alibakhshi A, Ranjbari J, Pilehvar-Soltanahmadi Y, et al. An update on phytochemicals in molecular target therapy of cancer: potential inhibitory effect on telomerase activity. Curr Med Chem. 2016;23:2380–2393.
  • Politis M, Dmytrowich A. Promotion of second intention wound healing by emu oil lotion: comparative results with furasin, polysporin, and cortisone. Plast Reconstr Surg. 1998;102:2404–2407.
  • Mashtoub S. Potential therapeutic applications for emu oil. Lipid Technol. 2017;29:28–31.
  • Abimosleh SM, Lindsay RJ, Butler RN, et al. Emu oil increases colonic crypt depth in a rat model of ulcerative colitis. Dig Dis Sci. 2012;57:887–896.
  • Reardon M, Gobern S, Martinez K, et al. Oleic acid attenuates trans-10, cis-12 conjugated linoleic acid-mediated inflammatory gene expression in human adipocytes. Lipids. 2012;47:1043–1051.
  • Yoganathan S, Nicolosi R, Wilson T, et al. Antagonism of croton oil inflammation by topical emu oil in CD-1 mice. Lipids. 2003;38:603–607.
  • Pilehvar-Soltanahmadi Y, Nouri M, Martino MM, et al. Cytoprotection, proliferation and epidermal differentiation of adipose tissue-derived stem cells on emu oil based electrospun nanofibrous mat. Exp Cell Res. 2017;357:192–201.
  • Chakrapani VY, Gnanamani A, Giridev V, et al. Electrospinning of type I collagen and PCL nanofibers using acetic acid. J Appl Polym Sci. 2012;125:3221–3227.
  • Unnithan AR, Pichiah PT, Gnanasekaran G, et al. Emu oil-based electrospun nanofibrous scaffolds for wound skin tissue engineering. Colloids Surf A: Physicochem Eng Asp. 2012;415:454–460.
  • Hu Y, Cai K, Luo Z, et al. Regulation of the differentiation of mesenchymal stem cells in vitro and osteogenesis in vivo by microenvironmental modification of titanium alloy surfaces. Biomaterials. 2012;33:3515–3528.
  • Pauklin S, Vallier L. The cell-cycle state of stem cells determines cell fate propensity. Cell. 2014;156:1338.
  • Fatimah SS, Tan GC, Chua KH, et al. Effects of epidermal growth factor on the proliferation and cell cycle regulation of cultured human amnion epithelial cells. J Biosci Bioeng. 2012;114:220–227.
  • Saei Arezoumand K, Alizadeh E, Pilehvar-Soltanahmadi Y, et al. An overview on different strategies for the stemness maintenance of MSCs. Artif Cells Nanomed Biotechnol. Forthcoming. [17 p.]. http://dx.doi.org/10.1080/21691401.2016.1246452.
  • Fong H, Hohenstein KA, Donovan PJ. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells. 2008;26:1931–1938.
  • Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res. 2007;17:42–49.
  • Tsai C-C, Hung S-C. Functional roles of pluripotency transcription factors in mesenchymal stem cells. Cell Cycle. 2012;11:3711–3712.
  • Zhang P, Andrianakos R, Yang Y, et al. Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression. J Biol Chem. 2010;285:9180–9189.
  • Hassan D, Nosratollah Z. Trichostatin A-induced apoptosis is mediated by Krüppel-like factor 4 in ovarian and lung cancer. Asian Pac J Cancer Prev. 2014;15:6581–6586.
  • Varlakhanova NV, Cotterman RF, Morgan J, et al. Myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation. 2010;80:9–19.
  • Zuk P. Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells. 2013;2013:1–35.
  • Abraham LC, Vorrasi J, Kaplan DL. Impact of collagen structure on matrix trafficking by human fibroblasts. J Biomed Mater Res A. 2004;70:39–48.
  • Abimosleh SM, Tran CD, Howarth GS. Emu oil: a novel therapeutic for disorders of the gastrointestinal tract? J Gastroenterol Hepatol. 2012;27:857–861.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.